Sanofi-Aventis
Sanofi name change sees Aventis dropped
May 9, 2011Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis
Sanofi-Aventis will now just be known as Sanofi after the French pharma company’s shareholders agreed to change its name. Following …
Sanofi signs malaria research alliance
May 5, 2011Research and Development Medicines for Malaria Venture, Sanofi-Aventis, malaria
Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …
Plavix sales plummet in England
May 5, 2011Sales and Marketing BMS, Plavix, Sanofi-Aventis, clopidogrel
GP prescriptions for Plavix saw a significant drop in England last year as doctors opted for cheaper generic forms of …
Genzyme MS drug shines in head-to-head trial with Rebif
April 18, 2011Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis
Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …
Sanofi signs ophthalmology research collaboration
March 25, 2011Research and Development Fovea, Sanofi-Aventis, Vision Institute, ophthalmology
Sanofi-Aventis has penned a collaboration with one of the main eye disease research centres in Europe. The three-year agreement between …
Sanofi prostate cancer drug Jevtana approved in Europe
March 21, 2011Sales and Marketing Jevtana, Sanofi-Aventis, TROPIC clinical trial, cabazitaxel, cancer drugs, chemotherapy, prostate cancer
Sanofi-Aventis’ new chemotherapy treatment Jevtana has followed up on its US approval last year by receiving the green light in …
Former Gates Foundation director joins Sanofi
March 14, 2011Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development
Sanofi-Aventis has appointed a former Gates Foundation director to chair its strategic development and scientific advisory council. Dr Richard Klausner …
Sanofi lung cancer drug fails in late-stage trial
March 11, 2011Research and Development Cancer, NSCLC, Regeneron, Sanofi-Aventis, aflibercept, non-small cell lung cancer
Sanofi-Aventis’ lung cancer drug aflibercept has failed to meet its primary endpoint in a phase III trial. The late-stage VITAL …
Digital Pharma: online campaign directory updated
March 4, 2011Medical Communications, Sales and Marketing Digital Pharma blog, Novartis, Pfizer, Sanofi-Aventis, VTE, diabetes, erectile dysfunction, pharmacist educaiton, venous thromboembolism, viagra
The latest update to the Digital Pharma links directory covers its online campaigns section and includes a pharmacist networking portal …
Sanofi picks two agencies for UK diabetes account
February 25, 2011Medical Communications Lantus, Sanofi-Aventis, Tudor Reilly, diabetes, medical communications account win, red health
Healthcare PR agencies Tudor Reilly and Red Health have jointly won the Sanofi-Aventis UK diabetes account after a five-way pitch. …
Digital Pharma: Sanofi shifts video focus to YouTube
February 24, 2011Medical Communications Digital Pharma blog, Sanofi-Aventis, online pharma video, youtube
Sanofi-Aventis has scaled back its online video ambitions and moved its web TV channel to YouTube. The move sees the …
Sanofi partners on dengue vaccine awareness
February 22, 2011Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines
Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
Generics force Sanofi into standstill
February 9, 2011Sales and Marketing 2010 pharma results, Jevtana, Multaq, Sanofi, Sanofi-Aventis, generics
An onslaught of generic competition combined with healthcare cuts in the US and Europe meant Sanofi-Aventis’ revenues were brought to …
Pharma-NHS diabetes project begins
February 9, 2011Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working
A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …
Pharmaceutical facility news in brief
February 8, 2011Manufacturing and Production Baxter International, Famar, Lannett, Qatar Pharma, Sanofi-Aventis, Takeda Pharmaceutical Co
A round-up of news involving manufacturing facilities includes updates from Takeda, Famar/Sanofi, Qatar Pharma, Lannett and Baxter. Takeda Pharmaceutical Co …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
